Management tracks

Cancer company ImmunoGen Inc. (NASDAQ:IMGN) hired Mark Enyedy as president, CEO and a director, effective May 16. Enyedy was EVP and head of corporate development at Shire plc (LSE:SHP; NASDAQ:SHPG). He replaces Daniel Junius, who will retire as president and CEO while remaining a director.

Molecular diagnostic company Trovagene Inc. (NASDAQ:TROV) hired William Welch as CEO and said chief commercial officer Matthew Posard departed. Welch was president and CEO of Sequenom Inc. (NASDAQ:SQNM). ...